Get the latest updates as we post them — right on your browser

. Last Updated: 07/27/2016

AstraZeneca Deal

STOCKHOLM, Sweden -- British-Swedish pharmaceuticals group AstraZeneca PLC leapt to the top of the global prescription drugs standing Tuesday after shareholders in Sweden's Astra approved the $36 billion merger.

Astra and Britain's Zeneca said that the conditions for the takeover offer made by Zeneca for Astra were satisfied and the merger was complete.

The merger propels the group to the top of the rankings for prescription-drug companies based on 1998 sales figures.